Back

Comparison of CHA2DS2-VASc, CHA2DS2-VASc-60 and CHA2DS2-VA score for stroke risk stratification in patients with atrial fibrillation: insights from the ETNA-AF-China study

30 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Prevalence and incidence of atrial fibrillation: risk stratification Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Chang-Sheng Ma

Beijing Anzhen Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Postoperative atrial fibrillation as a marker of atrial myopathy in aortic stenosis: a prospective surgical cohort analysis
Doctor L. Cristin (Quebec, CA)
Abstract Slides Video
Presentation thumbnail
POAF duration modifies long-term stroke prediction by the CHA₂DS₂-VASc score after cardiac surgery
Doctor A. Taseva Vasileva (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Panoramic vs. empiric mapping in the diagnosis and treatment of persistent atrial fibrillation - meta analysis
Doctor R. Gagyi (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Identification of the mapping-based voltage-derived parameter for accurate arrhythmia outcome prediction in patients undergoing a first PVI
Doctor T. Huang (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Type 2 diabetes and atrial fibrillation: triangulation of observational, genetic, and trial evidence
Mr A. Von Ende (Oxford, GB)

Access the full session

Session thumbnail
Prevalence and incidence of atrial fibrillation: risk stratification

The Event

Event poster

ESC Congress 2026

30 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
28 August 2026
thumbnail
Congress Presentation
A data-driven cluster analysis of stroke phenotypes in Asian patients with atrial fibrillation: refinement of the CHA2DS2-VASc score
18 April 2023
thumbnail
Congress Presentation
Stroke risk of females versus males in asian patients with atrial fibrillation: a temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores
29 August 2025
thumbnail
Congress Presentation
One-year effectiveness and safety outcomes of edoxaban treatment in Chinese patients with atrial fibrillation: First snapshot of more than 4,800 patients from the ETNA-AF-China study
8 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources